Correspondence 0001193125-25-013303 from Vor Biopharma Inc. (VOR)
Vor Biopharma Inc.
Date: Jan. 27, 2025 · CIK: 0001817229 · Accession: 0001193125-25-013303
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-284380
Letter
VOR BIOPHARMA INC.
100 Cambridgepark Drive, Suite 101
Cambridge, MA 02140
January 27, 2025
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attn: Alan Campbell
Re:
Vor Biopharma Inc.
Registration Statement on Form S-3 (File No. 333-284380)
Request for Acceleration of Effective Date
Requested Date: January 29, 2025
Requested Time: 4:00 p.m. Eastern Time
Ladies and Gentlemen:
In accordance with Rule 461 under the Securities Act of 1933, as amended, the undersigned registrant (the “Registrant”) hereby requests that the Securities and Exchange Commission take appropriate action to cause the above-referenced Registration Statement on Form S-3 (File No. 333-284380) (the “Registration Statement”) to become effective on January 29, 2025, at 4:00 p.m. Eastern Time, or as soon thereafter as is practicable.
Once the Registration Statement has been declared effective, please orally confirm that event with Katie Kazem of Cooley LLP, counsel to the Registrant, at (703) 456-8043, or in her absence, Divakar Gupta at (212) 479-6474.
Very truly yours,
Vor Biopharma Inc.
Show Raw Text
CORRESP 1 filename1.htm CORRESP VOR BIOPHARMA INC. 100 Cambridgepark Drive, Suite 101 Cambridge, MA 02140 January 27, 2025 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attn: Alan Campbell Re: Vor Biopharma Inc. Registration Statement on Form S-3 (File No. 333-284380) Request for Acceleration of Effective Date Requested Date: January 29, 2025 Requested Time: 4:00 p.m. Eastern Time Ladies and Gentlemen: In accordance with Rule 461 under the Securities Act of 1933, as amended, the undersigned registrant (the “Registrant”) hereby requests that the Securities and Exchange Commission take appropriate action to cause the above-referenced Registration Statement on Form S-3 (File No. 333-284380) (the “Registration Statement”) to become effective on January 29, 2025, at 4:00 p.m. Eastern Time, or as soon thereafter as is practicable. Once the Registration Statement has been declared effective, please orally confirm that event with Katie Kazem of Cooley LLP, counsel to the Registrant, at (703) 456-8043, or in her absence, Divakar Gupta at (212) 479-6474. Very truly yours, Vor Biopharma Inc. By: /s/ Robert Ang Robert Ang Chief Executive Officer